Mid-Atlantic Home Health Network Inc (MAHN) fair value: what the stock is really worth
As of Sep 18, 2026: fair value of Mid-Atlantic Home Health Network Inc $0.05, price $0.12, upside -58.3%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Mid-Atlantic Home Health Network Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.0001 – $1.00 · fair‑value band $0.0400 – $0.0700 · the $0.1200 price screens above the $0.0500 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow Mid-Atlantic Home Health Network in your weekly email
Every Wednesday you see whether Mid-Atlantic Home Health Network is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mid-Atlantic Home Health Network, Inc. provides integrated home health products and services for the home health care industry in Virginia, Maryland, and the District of Columbia. It also provides healthcare staffing and private duty nursing services to hospitals, nursing homes, and other facilities, such as clinics, correctional facilities, and schools.
Show more
Mid-Atlantic Home Health Network, Inc. provides integrated home health products and services for the home health care industry in Virginia, Maryland, and the District of Columbia. It also provides healthcare staffing and private duty nursing services to hospitals, nursing homes, and other facilities, such as clinics, correctional facilities, and schools. Mid-Atlantic was incorporated as U-Can Resources, Inc. in 1979. The company changed its name to Petro-Sers Corporation in 1993 and to Mid-Atlantic Home Health Network, Inc. in 1994. The company is based in Manassas, Virginia. Mid-Atlantic Home Health Network, Inc. is 80% owned by Oak Springs NursingHome Limited Liability Company.
Stock analysis
Mid-Atlantic Home Health Network Inc (MAHN) currently trades at $0.1200, while our model-based Fair Value estimate is $0.0500, implying the stock looks roughly 140.0% overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $0.0700 per share, and 0 of the 13 models we run sit above the $0.1200 price.
Bear case: the Earnings-Based group reads lowest at $0.0300, and 13 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.0400 (bear) to $0.0700 (bull), the price of $0.1200 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Mid-Atlantic Home Health Network Inc reported revenue of $28.3M in FY2001 versus $14.7M in FY1998, a compound +24.5%/yr. Reported net income was −$35.2K in FY2001.
Key figures
Market cap $40.7M · P/E ratio 60.0 · P/S ratio 1.51 · EPS (TTM) $0.0020 · Net margin −0.1% · Return on equity 1.2% · Return on assets (EBIT) 12.1% · Operating margin 4.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 88% below its 52-week high and 97% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −58%, MAHN screens richer than that median.
Fair Value models
Bear $0.0400Fair Value $0.0500Bull $0.0700
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.68/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+0.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.5%
’98
’99
’00
’01
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
2.3% (1998) → 2.9% (2001)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
Compare Mid-Atlantic Home Health Network Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside−58% · Bottom 25%
Profitability
Return on equity (TTM)1% · Below median
Return on assets6% · Above median
Net margin (TTM)0% · Bottom 25%
Operating margin (TTM)4% · Below median
Growth and dividend
Revenue growth−3% · Bottom 25%
Balance sheet
Debt / equity0.20× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)60.0× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)0· sector 28
PAST (return on equity)5· sector 31
HEALTH (low debt)90· sector 89
DIVIDEND (yield)0· sector 43
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mid-Atlantic Home Health Network Inc Fair Value". https://www.fairvalue-calculator.com/stock/MAHN
Frequently asked questions
Is Mid-Atlantic Home Health Network Inc (MAHN) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0500 versus the last price from Sep 18, 2026 of $0.1200, about −58% upside (overvalued).
What is the fair value of MAHN?
Our model-based fair value for Mid-Atlantic Home Health Network Inc is $0.0500 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $0.1200.
What is the quality score of MAHN?
Mid-Atlantic Home Health Network Inc has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mid-Atlantic Home Health Network Inc (MAHN)?
Our model-based price target is the fair value of $0.0500 (as of Sep 24, 2026) from 14 valuation models. Cautious scenario $0.0400, optimistic scenario $0.0700. It is a calculation from audited fundamentals, not an analyst target.
What is the Mid-Atlantic Home Health Network Inc stock forecast for 2026?
Our models put fair value at $0.0500, about −58% upside versus the last price from Sep 18, 2026 of $0.1200 (overvalued). Cautious scenario $0.0400, optimistic scenario $0.0700. The calculation is refreshed regularly with new filings.
What is the revenue of Mid-Atlantic Home Health Network Inc (MAHN)?
Mid-Atlantic Home Health Network Inc reported trailing-twelve-month revenue of about $27.0M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Mid-Atlantic Home Health Network Inc (MAHN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mid-Atlantic Home Health Network Inc it is $0.0500 per share (as of Sep 24, 2026), against a price of $0.1200. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Mid-Atlantic Home Health Network Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, MAHN trades above its calculated fair value: price $0.1200, fair value $0.0500, a gap of about −58% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MAHN?
No. The price is what the market pays today ($0.1200); the fair value is what the company's own numbers justify ($0.0500). For Mid-Atlantic Home Health Network Inc the two are $0.0700 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mid-Atlantic Home Health Network Inc worth?
The market values Mid-Atlantic Home Health Network Inc at about $40.7M (market capitalisation, as of Sep 24, 2026). Per share that is $0.1200; our models calculate a fair value of $0.0500 per share.
What do the bullish and bearish scenarios say about MAHN?
Our models span a range for Mid-Atlantic Home Health Network Inc: cautious scenario $0.0400, base $0.0500, optimistic $0.0700 per share (as of Sep 24, 2026, price $0.1200). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MAHN?
Mid-Atlantic Home Health Network Inc trades at a price-to-earnings ratio of 60.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.0500 is built from several models across several years.
How solid is the balance sheet of Mid-Atlantic Home Health Network Inc (MAHN)?
Balance-sheet figures for Mid-Atlantic Home Health Network Inc (as of Sep 24, 2026): return on equity 1.2%, debt of 0.20 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is MAHN from its 52-week high?
Mid-Atlantic Home Health Network Inc trades at $0.1200, about 88% below its 52-week high of $1.00 and 97% above the low of $0.0610 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0500 is for.
Which stocks are comparable to Mid-Atlantic Home Health Network Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mid-Atlantic Home Health Network Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.1200, calculated fair value $0.0500 (−58%), Quality Score 50/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MAHN calculated?
We run Mid-Atlantic Home Health Network Inc through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0500, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Mid-Atlantic Home Health Network Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mid-Atlantic Home Health Network Inc (MAHN)?
The latest price we hold is from Sep 18, 2026 and stands at $0.1200. Our model-based fair value is $0.0500, about −58% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mid-Atlantic Home Health Network Inc right now?
The price sits above even our optimistic bull case ($0.0700). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Mid-Atlantic Home Health Network Inc
How large is the market capitalisation of Mid-Atlantic Home Health Network Inc (MAHN)?
The market capitalisation of Mid-Atlantic Home Health Network Inc is $40.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mid-Atlantic Home Health Network Inc (MAHN)?
The price-to-sales ratio of Mid-Atlantic Home Health Network Inc is 1.51 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mid-Atlantic Home Health Network Inc (MAHN)?
Earnings per share at Mid-Atlantic Home Health Network Inc are $0.0020 (price ÷ EPS = P/E 60.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Mid-Atlantic Home Health Network Inc (MAHN)?
The net margin of Mid-Atlantic Home Health Network Inc is −0.1% (fiscal year 2001). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mid-Atlantic Home Health Network Inc (MAHN)?
The return on equity (ROE) of Mid-Atlantic Home Health Network Inc is 1.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mid-Atlantic Home Health Network Inc (MAHN)?
On an EBIT basis the return on assets of Mid-Atlantic Home Health Network Inc is 12.1% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mid-Atlantic Home Health Network Inc (MAHN)?
The operating margin of Mid-Atlantic Home Health Network Inc is 4.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mid-Atlantic Home Health Network Inc (MAHN)?
Revenue at Mid-Atlantic Home Health Network Inc is growing −2.6% versus a year earlier (3y avg +24.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
Free · no account needed
Watch Mid-Atlantic Home Health Network Inc in the live analysis
One click puts Mid-Atlantic Home Health Network Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 24, 2026